32ACTIVITIES
1ORGS REPRESENTED
25BILLS
Revolving door — covered positions
Federal positions Meredith held before / during the 2-year LDA window. This is the credibility signal — who they were inside the building before they started lobbying it.
Intern - Senator Richard Burr
Intern - Senator Roger Wicker
Organizations represented
1Orgs whose LD-2 filings list Meredith as an active lobbyist, sorted by activity volume.
Bills they file on
25S. 229621 mentions
S. 35511 mentions
S. 65211 mentions
S. 83211 mentions
S. 86411 mentions
S. 89111 mentions
S. 93211 mentions
S. 141411 mentions
S. 195411 mentions
S. 265811 mentions
S. 334511 mentions
H.R. 94611 mentions
H.R. 126211 mentions
H.R. 149211 mentions
H.R. 221411 mentions
+ 10 more bills referenced in their activities
Topics in Filings
50Policy topics Meredith files on across all their LD-2 activities.
One Big Beautiful Bill Act×22
Inflation Reduction Act×22
Drug cost and pricing policy×22
BIOSECURE Act×21
Most Favored Nation×21
Supply chain policy×21
FDA Modernization×11
Bipartisan Health Care Act×11
Modernizing and Ensuring PBM Accountability×11
Biosimilar Red Tape Elimination Act×11
PBM Price Transparency and Accountability Act×11
Mikaela Naylon Give Kids a Chance Act×11
Show all 50 topics (+38 more) ▾
PBM Reform×11
HELP Copays Act×11
Accountability, and Integrity Now and for the Future×11
Vaccine policy×11
IRA price negotiation expansion policy×11
Pharmacy Benefit Manager reform×11
Drug importation policy×11
FDA policy×11
MAHA Commission Report×11
Make Our Children Healthy Again Competition policy×11
Orphan Drug Act×11
Antimicrobial resistance policy×11
Compounding policy×11
Clinical trial policy×11
Issues 340B drug discount program rebate and policy×11
Issues 340B rebate pilot program Patient assistance program policy×11
Biosimilar approval and reimbursement policy×11
Biosimilars Access and Affordability Act×11
Artificial intelligence policy×11
Part D redesign and policy×11
Part B policy×11
Medicare rebate policy×11
Center for Medicare and Medicaid Innovation×11
Medicaid rebate policy×11
GENErating cost Reductions for U.S×11
Medicare Against Rising Drugs Costs×11
CLEAR LABELS Act×10
Most Favored Patients Act×10
FAIR ACT×10
SECURE Rx Act×10
Biopharmaceutical innovation policy×10
International intellectual property and market access policy×10
Pricing and reimbursement policy×10
WTO TRIPS waiver policy×10
China outbound investment policy×10
US-UK Framework Agreement×10
Open Payments Expansion Act×1
User fee issues×1
Issue mix
LDA general-issue codes weighted by activity count.
Health Issues11
Medicare/Medicaid11
Trade (domestic/foreign)10